Caduvo turns a device description into a source-cited report — matched codes, payer-by-payer coverage, regulatory pathway, and freedom-to-operate exposure in under thirty seconds.
Paste a sentence, a spec sheet, or a 510(k) summary. No taxonomy to learn and no fields to fill.
Codes, payer-by-payer coverage, regulatory pathway, and FTO exposure — each matched, confidence-scored, and sourced.
Source-cited and export-ready in under thirty seconds. Rerun the moment the design changes.
A wrong coverage read strands a launch — so nothing here is a guess. Here's where the data comes from, what the confidence scores mean, and how current it stays.
Every code, filing, and patent comes from the primary record — CMS fee schedules and LCD/NCD coverage, FDA 510(k)/De Novo/PMA, USPTO. Each line in your report cites where it came from.
A 97% match means the matched descriptor scored 97 of 100 against your device — shown next to the code, with the descriptor it matched. You see why it matched and how strongly, never a black-box answer.
Code and fee data tracks CMS releases; FDA filings and patents follow their public data drops. Every report is stamped with the date its sources were last updated.
The data underneath is public. What teams actually pay for is the synthesis — and they pay for it one expensive engagement at a time. Here's what a single product's first year looks like the old way.
Every job above, on every device in your pipeline, rerun the moment the design changes — for less than a single consulting engagement.
A miscoded device or a missed coverage policy doesn't cost you a subscription — it strands a multi-million-dollar program at launch. The cheapest line item in your reimbursement strategy is being right the first time.
Every run covers the four questions a market-access decision turns on — each one matched to your device, confidence-scored, and sourced.
HCPCS, ICD-10, MS-DRG and more — matched to your device with confidence scoring and per-payer payout ranges.
Predicate device search, pathway recommendation (510(k), De Novo, PMA), and submission timeline estimates.
Scan the patent landscape for blocking claims, see competitor exposure, and rank infringement risk.
Revenue projections from real reimbursement data — unit economics, payer mix, site-of-care segmentation.
Every plan starts with a 14-day free trial — $0 today, cancel anytime. One predictable price per tier, billed annually — no surprise overages.
For solo consultants and early-stage teams pressure-testing reimbursement on a device or two before they scale.
The core tier for market-access and regulatory teams running an active pipeline — the work a consultant would bill six figures for.
For multi-product MedTech and investors running diligence at scale — with API access, security review, and white-glove deliverables.
Need a single answer, not a seat? Buy the deliverable. Each one stands in for a consulting mini-engagement at a fraction of the price and turnaround.
A full reimbursement + GTM strategy deck — codes, coverage, clearance path, payer objections, and launch sequence. A consulting engagement in 48 hours, not 8 weeks.
Request thisA reimbursement and regulatory risk read on an acquisition or investment target — the report a deal team needs before they wire.
Request thisConsultant engagements are quoted per device and usually take 4–8 weeks. Caduvo produces a comparable, source-cited analysis — matched codes, payer-by-payer coverage, and payment benchmarks — in under 30 seconds, with plans from $490/month.
Start from the device’s clinical use and search the CMS HCPCS and AMA CPT code sets for procedure and supply codes that match. Caduvo automates this: describe the device and it matches against 80,000+ medical codes (HCPCS, ICD-10, MS-DRG and more) with per-code coverage and payment data.
It depends on device risk class and whether a substantially equivalent predicate exists. Most moderate-risk devices clear via 510(k); novel moderate-risk devices use De Novo; high-risk Class III devices need PMA. Caduvo recommends a pathway with precedent clearances from FDA’s own databases.
Only when coverage criteria are met: a benefit category, a National or Local Coverage Determination (or contractor discretion), and correct coding. FDA clearance alone does not guarantee Medicare payment. Caduvo maps existing NCDs, LCDs, and payer policies to your device before you build.
Run a report on your device in under thirty seconds — then start a 14-day free trial, $0 today.